Epinephrine Market
Epinephrine Market Forecasts to 2030 - Global Analysis By Product (Auto-injector, Prefilled Syringe and Ampoules & Vials), Distribution Channel (Online Pharmacies, Hospital Pharmacies and Retail Pharmacies), Application and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $2.05 BN |
|
Projected Year Value (2030) |
US $4.87 BN |
|
CAGR (2023 - 2030) |
13.1% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
Asia Pacific |
|
Highest Growing Market |
Europe |
According to Stratistics MRC, the Global Epinephrine Market is accounted for $2.05 billion in 2023 and is expected to reach $4.87 billion by 2030 growing at a CAGR of 13.1% during the forecast period. Epinephrine is one of the most often used medications and hormones for treatment in various situations, including emergency treatment of type 1 hypersensitivity reactions such as anaphylaxis and allergic reactions brought on by foods, medicines, latex, insect bites, or stings. It functions by relaxing the airway muscles and constricting the blood vessels. The injection is offered in a variety of forms, including vials for subcutaneous injection, prefilled automated injection devices that already have the solution inside, and others. At the first indication of a severe allergic response, the injection is often administered as needed. Epinephrine acts swiftly to enhance breathing, speed up the heart, boost blood pressure, stop hives, and lessen facial, lip, and neck swelling.
According to the American College of Allergy, Asthma & Immunology (ACAAI), allergies are among the 6th leading causes of chronic diseases in the U.S. and have health expenditures of more than USD 18.00 billion. Also, more than 50 million Americans suffer from allergies every year.
Market Dynamics:
Driver:
Growing prevalence of anaphylaxis
Anaphylaxis is an acute allergic reaction to an antigen. It might occur seconds or minutes after the patient is exposed to an allergen. The first choice drug for anaphylaxis therapy is epinephrine. It avoids or lessens upper airway mucosal edema, hypotension, and shock by vasoconstrictor actions. Both developing and affluent nations are seeing an increase in demand for these items as anaphylaxis rates raise internationally. Major epinephrine market companies are concentrating on creating technologically sophisticated injectors in order to meet this expanding demand. Additionally, the approval of the generic version of these injectors by governments from different nations has substantially accelerated the market growth.
Restraint:
Inadequate reimbursement policies
People are generally unaware of the anaphylactic treatment choices in poor nations. Since it should always be handled as a medical emergency, the government provides particular requirements to help reduce the high cost of medical assistance. However, the laws governing auto-injector reimbursement are insufficient. Another reason for the poor uptake of auto-injectors in developing nations is a lack of R&D activity. However, the availability of substitute medication delivery methods and the inadequate reimbursement environment are limiting the market expansion.
Opportunity:
Adoption of AI
Modern therapy choices have increased due to the increasing frequency of medical illnesses involving anaphylaxis, cardiovascular diseases, respiratory diseases (asthma), and others. AI replicates clinical trials and offers insights into prospective outcomes by producing synthetic patient data. Informed judgments on which medications to commercialize and how to create clinical trials that are more successful and efficient can thus be made by pharmaceutical firms. AI-enabled injectors make self-administration simple, boost patient compliance, lessen anxiety, and provide precise dosage. Growing innovations in auto-injectors, such as those with AI capabilities and needle-free auto-injectors are opening up the lucrative potential for the marketplace.
Threat:
High cost of auto-injectors
Auto-injectors are used to treat severe allergic responses (anaphylaxis) and asthma attacks during medical emergencies. The demand for these injections is rising quickly because to the growing need for efficient treatment alternatives for severe allergic responses, such as anaphylaxis. Thus, the high price of these types of injectors, coupled with patients' growing need for effective treatment choices and the higher out-of-pocket costs related to the auto-injectors, are partially responsible for the less worthy market penetration of these products.
Covid-19 Impact
The corona epidemic had a detrimental effect on the expansion of the epinephrine market worldwide. The identification and treatment of various disorders, including anaphylaxis, declined as a result of the decrease in patient visits to healthcare facilities. More than 40% of major firms saw sales declines. Additionally, during the COVID-19 epidemic, the market's development was constrained by disruptions in the supply chain and the manufacturers of these auto-injectors. However, the measures implemented by governments of many nations for the control of allergic responses during the COVID-19 pandemic helped the market's expansion in the post-pandemic period.
The auto-injectors segment is expected to be the largest during the forecast period
The auto-injectors segment is estimated to have a lucrative growth, due to its wide range of benefits. It is the most prevalent variety of disposable, single-use, spring-loaded syringe. Auto-injectors can be used to treat acute anaphylaxis in cases of urgency and delivered intramuscularly. It manages asthma episodes and severe allergic responses (anaphylaxis). This medicine is injected either into a muscle or subcutaneously. It functions by contracting the blood vessels and relaxing the muscles of the airways. They are also simple to use, easy to find, and easy to transport, thereby creating demand for these products in the market.
The cardiac arrest segment is expected to have the highest CAGR during the forecast period
The cardiac arrest segment is anticipated to witness the fastest CAGR growth during the forecast period. Cardiac arrest is characterized by an abrupt loss of respiration, cardiac function, and consciousness. The heart's ability to pump blood across the body, including the brain and lungs, is typically disrupted. The main medication used in CPR to reverse the symptoms of cardiac arrest is epinephrine. Epinephrine is continuously infused into the patient during cardiac arrest to lower the danger of blood flow. During CPR, the adrenergic effects of epinephrine boost cerebral and myocardial blood flow. Its abilities to stimulate -adrenergic receptors are fuelling the segment demand.
Region with largest share:
Asia Pacific is projected to hold the largest market share during the forecast period. This region has a significant prevalence owing to modifying regulatory policies for the adoption of auto-injectors. To fulfil the demand, Asian businesses are growing their worldwide footprint. In China, Taiwan, and South Korea, epinephrine enterprises are expanding technological and medicinal advances. Health systems across the region are leveraging generic medications increasingly to minimize costs. The market demand is also being fuelled by factors like superior R&D programs and efforts, first-rate healthcare infrastructure, and superior reimbursement practices in the area.
Region with highest CAGR:
Europe is projected to have the highest CAGR over the forecast period, owing to the growth of technologically advanced products. There is raising prevalence of various disorders such as anaphylaxis, cardiovascular diseases, and others in this region. Europe has a high prevalence of wheat allergies. 61.6% of people in the region, according to various European publications, have food allergies. The region's elderly population and a stronger government commitment to providing affordable healthcare are driving forces behind the need for epinephrine.
Key players in the market
Some of the key players profiled in the Epinephrine Market include Teva Pharmaceutical Industries Ltd., Abbott Laboratories, Novartis AG, Amneal Pharmaceuticals, Viatris Inc, Lincoln Medical Centre Ltd., Kaleo Inc, Aurum Pharma Lab, Bausch Health Companies, Medeca Pharma AB, Antares Pharma, Inc., Mylan N.V., Impax Laboratories LLC, Adamis Pharmaceuticals Corporation, Amedra Pharmaceuticals, ALK Abello A/S, Sanofi S.A., Grand Pharma, Harvest Pharmaceuticals and Bioprojet Pharma.
Key Developments:
In November 2021, Mylan N.V. and Upjohn, Pfizer Inc.’s division formed a global pharmaceutical company called Viatris Inc. to develop products in therapeutic areas such as central nervous system and anaesthesia, infectious disease, and cardiovascular diseases around the world.
In October 2021, Bausch Health Companies Inc. launched Emerade injection of dosages 0.3mg and 0.5mg in Canada for the emergency treatment of anaphylactic reactions in patients. This product launch created a new treatment option for anaphylaxis in Canada.
In May 2021, Kaleo, Inc. announced the availability of ALLERJECT auto-injector injection in Canada. With this availability, Canadian patients could access different treatment options for anaphylaxis.
In August 2019, Teva Pharmaceutical Industries announced the availability of the FDA-approved generic version of EpiPen Jr®1 (epinephrine injection, USP) Auto-Injector, 0.15 mg, in the U.S. The product is available in most retail pharmacies, and the Wholesale Acquisition Cost is $3002 for a 2-pack.
In July 2019, Novartis announced the US retail launch of SYMJEPI™ (epinephrine) 0.3 mg and 0.15 mg Injections, making both the adult and paediatric doses immediately available in local pharmacies across the nation.
Products Covered:
• Auto-injector
• Prefilled Syringe
• Ampoules & Vials
Distribution Channels Covered:
• Online Pharmacies
• Hospital Pharmacies
• Retail Pharmacies
Applications Covered:
• Superficial Bleeding
• Anaphylaxis
• Respiratory Disorders
• Cardiac Arrest
• Other Applications
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Epinephrine Market, By Product
5.1 Introduction
5.2 Auto-injector
5.3 Prefilled Syringe
5.4 Ampoules & Vials
6 Global Epinephrine Market, By Distribution Channel
6.1 Introduction
6.2 Online Pharmacies
6.3 Hospital Pharmacies
6.4 Retail Pharmacies
7 Global Epinephrine Market, By Application
7.1 Introduction
7.2 Superficial Bleeding
7.3 Anaphylaxis
7.4 Respiratory Disorders
7.5 Cardiac Arrest
7.6 Other Applications
8 Global Epinephrine Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Teva Pharmaceutical Industries Ltd.
10.2 Abbott Laboratories
10.3 Novartis AG
10.4 Amneal Pharmaceuticals
10.5 Viatris Inc
10.6 Lincoln Medical Centre Ltd.
10.7 Kaleo Inc
10.8 Aurum Pharma Lab
10.9 Bausch Health Companies
10.10 Medeca Pharma AB
10.11 Antares Pharma, Inc.
10.12 Mylan N.V.
10.13 Impax Laboratories LLC
10.14 Adamis Pharmaceuticals Corporation
10.15 Amedra Pharmaceuticals
10.16 ALK Abello A/S
10.17 Sanofi S.A.
10.18 Grand Pharma
10.19 Harvest Pharmaceuticals
10.20 Bioprojet Pharma
List of Tables
1 Global Epinephrine Market Outlook, By Region (2021-2030) ($MN)
2 Global Epinephrine Market Outlook, By Product (2021-2030) ($MN)
3 Global Epinephrine Market Outlook, By Auto-injector (2021-2030) ($MN)
4 Global Epinephrine Market Outlook, By Prefilled Syringe (2021-2030) ($MN)
5 Global Epinephrine Market Outlook, By Ampoules & Vials (2021-2030) ($MN)
6 Global Epinephrine Market Outlook, By Distribution Channel (2021-2030) ($MN)
7 Global Epinephrine Market Outlook, By Online Pharmacies (2021-2030) ($MN)
8 Global Epinephrine Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
9 Global Epinephrine Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
10 Global Epinephrine Market Outlook, By Application (2021-2030) ($MN)
11 Global Epinephrine Market Outlook, By Superficial Bleeding (2021-2030) ($MN)
12 Global Epinephrine Market Outlook, By Anaphylaxis (2021-2030) ($MN)
13 Global Epinephrine Market Outlook, By Respiratory Disorders (2021-2030) ($MN)
14 Global Epinephrine Market Outlook, By Cardiac Arrest (2021-2030) ($MN)
15 Global Epinephrine Market Outlook, By Other Applications (2021-2030) ($MN)
16 North America Epinephrine Market Outlook, By Country (2021-2030) ($MN)
17 North America Epinephrine Market Outlook, By Product (2021-2030) ($MN)
18 North America Epinephrine Market Outlook, By Auto-injector (2021-2030) ($MN)
19 North America Epinephrine Market Outlook, By Prefilled Syringe (2021-2030) ($MN)
20 North America Epinephrine Market Outlook, By Ampoules & Vials (2021-2030) ($MN)
21 North America Epinephrine Market Outlook, By Distribution Channel (2021-2030) ($MN)
22 North America Epinephrine Market Outlook, By Online Pharmacies (2021-2030) ($MN)
23 North America Epinephrine Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
24 North America Epinephrine Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
25 North America Epinephrine Market Outlook, By Application (2021-2030) ($MN)
26 North America Epinephrine Market Outlook, By Superficial Bleeding (2021-2030) ($MN)
27 North America Epinephrine Market Outlook, By Anaphylaxis (2021-2030) ($MN)
28 North America Epinephrine Market Outlook, By Respiratory Disorders (2021-2030) ($MN)
29 North America Epinephrine Market Outlook, By Cardiac Arrest (2021-2030) ($MN)
30 North America Epinephrine Market Outlook, By Other Applications (2021-2030) ($MN)
31 Europe Epinephrine Market Outlook, By Country (2021-2030) ($MN)
32 Europe Epinephrine Market Outlook, By Product (2021-2030) ($MN)
33 Europe Epinephrine Market Outlook, By Auto-injector (2021-2030) ($MN)
34 Europe Epinephrine Market Outlook, By Prefilled Syringe (2021-2030) ($MN)
35 Europe Epinephrine Market Outlook, By Ampoules & Vials (2021-2030) ($MN)
36 Europe Epinephrine Market Outlook, By Distribution Channel (2021-2030) ($MN)
37 Europe Epinephrine Market Outlook, By Online Pharmacies (2021-2030) ($MN)
38 Europe Epinephrine Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
39 Europe Epinephrine Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
40 Europe Epinephrine Market Outlook, By Application (2021-2030) ($MN)
41 Europe Epinephrine Market Outlook, By Superficial Bleeding (2021-2030) ($MN)
42 Europe Epinephrine Market Outlook, By Anaphylaxis (2021-2030) ($MN)
43 Europe Epinephrine Market Outlook, By Respiratory Disorders (2021-2030) ($MN)
44 Europe Epinephrine Market Outlook, By Cardiac Arrest (2021-2030) ($MN)
45 Europe Epinephrine Market Outlook, By Other Applications (2021-2030) ($MN)
46 Asia Pacific Epinephrine Market Outlook, By Country (2021-2030) ($MN)
47 Asia Pacific Epinephrine Market Outlook, By Product (2021-2030) ($MN)
48 Asia Pacific Epinephrine Market Outlook, By Auto-injector (2021-2030) ($MN)
49 Asia Pacific Epinephrine Market Outlook, By Prefilled Syringe (2021-2030) ($MN)
50 Asia Pacific Epinephrine Market Outlook, By Ampoules & Vials (2021-2030) ($MN)
51 Asia Pacific Epinephrine Market Outlook, By Distribution Channel (2021-2030) ($MN)
52 Asia Pacific Epinephrine Market Outlook, By Online Pharmacies (2021-2030) ($MN)
53 Asia Pacific Epinephrine Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
54 Asia Pacific Epinephrine Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
55 Asia Pacific Epinephrine Market Outlook, By Application (2021-2030) ($MN)
56 Asia Pacific Epinephrine Market Outlook, By Superficial Bleeding (2021-2030) ($MN)
57 Asia Pacific Epinephrine Market Outlook, By Anaphylaxis (2021-2030) ($MN)
58 Asia Pacific Epinephrine Market Outlook, By Respiratory Disorders (2021-2030) ($MN)
59 Asia Pacific Epinephrine Market Outlook, By Cardiac Arrest (2021-2030) ($MN)
60 Asia Pacific Epinephrine Market Outlook, By Other Applications (2021-2030) ($MN)
61 South America Epinephrine Market Outlook, By Country (2021-2030) ($MN)
62 South America Epinephrine Market Outlook, By Product (2021-2030) ($MN)
63 South America Epinephrine Market Outlook, By Auto-injector (2021-2030) ($MN)
64 South America Epinephrine Market Outlook, By Prefilled Syringe (2021-2030) ($MN)
65 South America Epinephrine Market Outlook, By Ampoules & Vials (2021-2030) ($MN)
66 South America Epinephrine Market Outlook, By Distribution Channel (2021-2030) ($MN)
67 South America Epinephrine Market Outlook, By Online Pharmacies (2021-2030) ($MN)
68 South America Epinephrine Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
69 South America Epinephrine Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
70 South America Epinephrine Market Outlook, By Application (2021-2030) ($MN)
71 South America Epinephrine Market Outlook, By Superficial Bleeding (2021-2030) ($MN)
72 South America Epinephrine Market Outlook, By Anaphylaxis (2021-2030) ($MN)
73 South America Epinephrine Market Outlook, By Respiratory Disorders (2021-2030) ($MN)
74 South America Epinephrine Market Outlook, By Cardiac Arrest (2021-2030) ($MN)
75 South America Epinephrine Market Outlook, By Other Applications (2021-2030) ($MN)
76 Middle East & Africa Epinephrine Market Outlook, By Country (2021-2030) ($MN)
77 Middle East & Africa Epinephrine Market Outlook, By Product (2021-2030) ($MN)
78 Middle East & Africa Epinephrine Market Outlook, By Auto-injector (2021-2030) ($MN)
79 Middle East & Africa Epinephrine Market Outlook, By Prefilled Syringe (2021-2030) ($MN)
80 Middle East & Africa Epinephrine Market Outlook, By Ampoules & Vials (2021-2030) ($MN)
81 Middle East & Africa Epinephrine Market Outlook, By Distribution Channel (2021-2030) ($MN)
82 Middle East & Africa Epinephrine Market Outlook, By Online Pharmacies (2021-2030) ($MN)
83 Middle East & Africa Epinephrine Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
84 Middle East & Africa Epinephrine Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
85 Middle East & Africa Epinephrine Market Outlook, By Application (2021-2030) ($MN)
86 Middle East & Africa Epinephrine Market Outlook, By Superficial Bleeding (2021-2030) ($MN)
87 Middle East & Africa Epinephrine Market Outlook, By Anaphylaxis (2021-2030) ($MN)
88 Middle East & Africa Epinephrine Market Outlook, By Respiratory Disorders (2021-2030) ($MN)
89 Middle East & Africa Epinephrine Market Outlook, By Cardiac Arrest (2021-2030) ($MN)
90 Middle East & Africa Epinephrine Market Outlook, By Other Applications (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
